MOUNTAIN VIEW, Calif., Feb. 3, 2021 /PRNewswire/ -- Synopsys, Inc. (Nasdaq: SNPS) today announced it will report results for the first quarter fiscal year 2021 on Wednesday, Feb. 17, 2021, after the market close. A conference call to review the results will begin at 2:00 p.m. PT (5:00 p.m. ET) and will be hosted by Aart […]

SAN JOSE, Calif., Feb. 3, 2021 /PRNewswire/ -- eBay Inc. (Nasdaq: EBAY), a global commerce leader that connects millions of buyers and sellers around the world, today reported financial results for its fourth quarter and full year ended December 31, 2020. "I am proud eBay was able to be there for our buyers, sellers and community, especially […]

MILPITAS, Calif., Feb. 3, 2021 /PRNewswire/ -- KLA Corporation (NASDAQ: KLAC) today announced operating results for its second quarter of fiscal year 2021, which ended on Dec. 31, 2020, and reported GAAP net income attributable to KLA of $457 million and GAAP earnings per diluted share attributable to KLA of $2.94 on revenue of $1.65 billion. Link: https://mma.prnewswire.com/media/806571/KLA_Corporation_Logo.jpg […]

FOSTER CITY, Calif., Feb. 3, 2021 /PRNewswire/ -- QuinStreet, Inc. (Nasdaq: QNST), a leader in performance marketplace technologies and services for the financial services and home services industries, today announced financial results for the fiscal second quarter ended December 31, 2020. For the second quarter, the Company reported revenue of $135.0 million. Revenue excluding divested businesses […]

SAN DIEGO, Feb. 3, 2021 /PRNewswire/ -- Qualcomm Incorporated (NASDAQ: QCOM) today announced the Company's financial results for its first quarter of fiscal 2021 through an earnings release that is available on the Qualcomm Investor Relations website at http://investor.qualcomm.com/results.cfm. The earnings release will be furnished to the Securities and Exchange Commission (SEC) on a Form […]

CUPERTINO, Calif., Feb. 3, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and potentially lifesaving therapies based on its endogenous epigenetic regulator program, today announced that it is commencing an underwritten public offering of its common stock […]

THOUSAND OAKS, Calif., Feb. 3, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced a three-year, Golden Ticket sponsorship of the BioLabs LA at The Lundquist Institute (TLI) life sciences co-working space to accelerate the development of new therapies, medical devices, and diagnostics to advance and improve human health. The BioLabs at TLI shared laboratory space was created to […]